| |
Influence of conduction disturbances on clinical outcome in patients with acute myocardial infarction receiving thrombolysis (results from the ARGAMI-2 study)
Am J Cardiol (2004);93:76-80
A. Abidov, et al. |
| |
Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction
Circulation (2004);109:2480-6
E. M. Antman and F. Van de Werf |
| |
Therapeutic delay and reduced functional status six months after thrombolysis for acute myocardial infarction
Am J Cardiol (2004);94:415-20
J. Avorn, et al. |
| |
Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction
Am J Cardiol (2004);93:1465-8
A. S. Binbrek, et al. |
| |
Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial
Am Heart J (2004);148:566-73
E. Bjorklund, et al. |
| |
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy)
Am J Cardiol (2004);94:859-63
F. A. Cura, et al. |
| |
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry
Circulation (2004);110:1909-15
N. Danchin, et al. |
| |
Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial
Lancet (2004);364:1045-53
F. Fernandez-Aviles, et al. |
| |
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries
Am J Cardiol (2004);94:178-81
G. S. Gardner, et al. |
| |
Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction
Am J Cardiol (2004);94:108-11
C. M. Gibson, et al. |
| |
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction
J Am Coll Cardiol (2004);44:980-7
C. M. Gibson, et al. |
| |
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial
J Am Coll Cardiol (2004);43:542-8
H. S. Gurm, et al. |
| |
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest (2004);126:513S-548S
R. A. Harrington, et al. |
| |
Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project
Am Heart J (2004);148:86-91
T. Huynh, et al. |
| |
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)
Am J Cardiol (2004);93:458-61
D. E. Kandzari, et al. |
| |
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial
Jama (2004);291:947-54
A. Kastrati, et al. |
| |
Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction
Am Heart J (2004);147:253-9
R. H. Mehta, et al. |
| |
Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
Am J Cardiol (2004);93:822-5
P. A. Merlini, et al. |
| |
Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase
Am J Cardiol (2004);93:195-8
P. A. Merlini, et al. |
| |
Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?
Am J Cardiol (2004);94:772-4
B. K. Nallamothu, et al. |
| |
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest (2004);126:576S-599S
J. J. Popma, et al. |
| |
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction
J Am Coll Cardiol (2004);43:549-56
M. T. Roe, et al. |
| |
A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction
J Am Coll Cardiol (2004);44:2073-9
A. Schomig, et al. |
| |
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction
Am Heart J (2004);147:993-8
P. R. Sinnaeve, et al. |
| |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest (2004);126:600S-608S
P. D. Stein, et al. |
| |
A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial
J Am Coll Cardiol (2004);44:287-96
A. G. Sutton, et al. |
| |
Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis
Am J Cardiol (2005);95:100-1
A. Betriu and M. Masotti |
| |
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy
Am J Cardiol (2005);95:337-42
A. J. Kirtane, et al. |
| |
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction
Am J Cardiol (2005);95:383-6
H. Q. Ly, et al. |
| |
| |
| |
 |